Current pharmaceutical design of antituberculosis drugs: future perspectives

Current Pharmaceutical Design
Alejandro Speck-PlancheVicente de Paulo-Emerenciano

Abstract

The increasing resistance of Mycobacterium tuberculosis to the existing drugs has alarmed the worldwide scientific community. In an attempt to overcome this problem computer-aided drug design has provide an extraordinary support to the different strategies in drug discovery. There are around 250 biological receptors like enzymes that can be used in principle, for the design of antituberculosis compounds that act by a specific mechanism of action. Also, there more than 5000 compound available in the literature, and that constitute important information in order to search new molecular patterns for the design of new antituberculosis agents. The purpose of this paper is to explored the current state of drug discovery of antituberculosis agents and how the different strategies supported by computer-aided drug design methods has influenced in a determinant way in the design of new molecular entities that can result the future antituberculosis drugs.

Citations

Nov 26, 2013·BMC Complementary and Alternative Medicine·Ramón Enrique Robles-ZepedaAdriana Garibay-Escobar
Oct 27, 2011·Nanomedicine·Marina PinheiroSalette Reis
Jun 1, 2016·International Journal of Mycobacteriology·Jean Bosco JoudaCéline Nguefeu Nkenfou
Sep 18, 2012·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Shanmugam Anusuya, Jeyakumar Natarajan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.